Search Results - "Liu, Yong-Yu" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study

by Zhong, Wen-Zhao, Wang, Qun, Mao, Wei-Min, Xu, Song-Tao, Wu, Lin, Shen, Yi, Liu, Yong-Yu, Chen, Chun, Cheng, Ying, Xu, Lin, Wang, Jun, Fei, Ke, Li, Xiao-Fei, Li, Jian, Huang, Cheng, Liu, Zhi-Dong, Xu, Shun, Chen, Ke-Neng, Xu, Shi-Dong, Liu, Lun-Xu, Yu, Ping, Wang, Bu-Hai, Ma, Hai-Tao, Yan, Hong-Hong, Yang, Xue-Ning, Zhou, Qing, Wu, Yi-Long, Wu, Yi-Long, Wang, Qun, Mao, Wei-Min, Wu, Lin, Shen, Yi, Liu, Yong-Yu, Chen, Chun, Cheng, Ying, Xu, Lin, Wang, Jun, Fei, Ke, Li, Xiao-Fei, Li, Jian, Huang, Cheng, Liu, Zhi-Dong, Xu, Shun, Chen, Ke-Neng, Xu, Shi-Dong, Liu, Lun-Xu, Yu, Ping, Wang, Bu-Hai, Ma, Hai-Tao, Wang, Si-Yu, Hu, Jian, Liu, Wei, Li, Wei, Shi, Jian-Hua
Published in The lancet oncology (01.01.2018)

Get full text

Journal Article

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial

by Zhong, Wen-Zhao, Wang, Qun, Mao, Wei-Min, Xu, Song-Tao, Wu, Lin, Wei, Yu-Cheng, Liu, Yong-Yu, Chen, Chun, Cheng, Ying, Yin, Rong, Yang, Fan, Ren, Sheng-Xiang, Li, Xiao-Fei, Li, Jian, Huang, Cheng, Liu, Zhi-Dong, Xu, Shun, Chen, Ke-Neng, Xu, Shi-Dong, Liu, Lun-Xu, Yu, Ping, Wang, Bu-Hai, Ma, Hai-Tao, Yang, Jin-Ji, Yan, Hong-Hong, Yang, Xue-Ning, Liu, Si-Yang, Zhou, Qing, Wu, Yi-Long
Published in Journal of clinical oncology (01.03.2021)

Get full text

Journal Article

Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes

Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes

by Liu, Si-Yang, Bao, Hua, Wang, Qun, Mao, Wei-Min, Chen, Yedan, Tong, Xiaoling, Xu, Song-Tao, Wu, Lin, Wei, Yu-Cheng, Liu, Yong-Yu, Chen, Chun, Cheng, Ying, Yin, Rong, Yang, Fan, Ren, Sheng-Xiang, Li, Xiao-Fei, Li, Jian, Huang, Cheng, Liu, Zhi-Dong, Xu, Shun, Chen, Ke-Neng, Xu, Shi-Dong, Liu, Lun-Xu, Yu, Ping, Wang, Bu-Hai, Ma, Hai-Tao, Yan, Hong-Hong, Dong, Song, Zhang, Xu-Chao, Su, Jian, Yang, Jin-Ji, Yang, Xue-Ning, Zhou, Qing, Wu, Xue, Shao, Yang, Zhong, Wen-Zhao, Wu, Yi-Long
Published in Nature communications (08.11.2021)

Get full text

Journal Article

Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway

Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway

by Yang, Cheng-Liang, Liu, Yong-Yu, Ma, Ye-Gang, Xue, Yi-Xue, Liu, De-Gui, Ren, Yi, Liu, Xiao-Bai, Li, Yao, Li, Zhen
Published in PloS one (25.05.2012)

Get full text

Journal Article

Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy

Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy

by Chamcheu, Jean Christopher, Roy, Tithi, Uddin, Mohammad Burhan, Banang-Mbeumi, Sergette, Chamcheu, Roxane-Cherille N, Walker, Anthony L, Liu, Yong-Yu, Huang, Shile
Published in Cells (Basel, Switzerland) (31.07.2019)

Get full text

Journal Article

Ceramide Glycosylation Catalyzed by Glucosylceramide Synthase and Cancer Drug Resistance

Ceramide Glycosylation Catalyzed by Glucosylceramide Synthase and Cancer Drug Resistance

by Liu, Yong-Yu, Hill, Ronald A., Li, Yu-Teh
Published in Advances in Cancer Research (2013)

Get full text

Book Chapter Journal Article

Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models

Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer models

by Akl, Mohamed R, Ayoub, Nehad M, Mohyeldin, Mohamed M, Busnena, Belnaser A, Foudah, Ahmed I, Liu, Yong-Yu, Sayed, Khalid A Ei
Published in PloS one (21.05.2014)

Get full text

Journal Article

Resuscitating Wild-Type p53 Expression by Disrupting Ceramide Glycosylation: A Novel Approach to Target Mutant p53 Tumors

Resuscitating Wild-Type p53 Expression by Disrupting Ceramide Glycosylation: A Novel Approach to Target Mutant p53 Tumors

by LIU, Yong-Yu
Published in Cancer research (Chicago, Ill.) (15.10.2011)

Get full text

Journal Article

Sphingolipids and expression regulation of genes in cancer

Sphingolipids and expression regulation of genes in cancer

by Patwardhan, Gauri A., Liu, Yong-Yu
Published in Progress in lipid research (01.01.2011)

Get full text

Journal Article

Graviola (Annona muricata) Exerts Anti-Proliferative, Anti-Clonogenic and Pro-Apoptotic Effects in Human Non-Melanoma Skin Cancer UW-BCC1 and A431 Cells In Vitro: Involvement of Hedgehog Signaling

Graviola (Annona muricata) Exerts Anti-Proliferative, Anti-Clonogenic and Pro-Apoptotic Effects in Human Non-Melanoma Skin Cancer UW-BCC1 and A431 Cells In Vitro: Involvement of Hedgehog Signaling

by Chamcheu, Jean Christopher, Rady, Islam, Chamcheu, Roxane-Cherille N, Siddique, Abu Bakar, Bloch, Melissa B, Banang Mbeumi, Sergette, Babatunde, Abiola S, Uddin, Mohammad B, Noubissi, Felicite K, Jurutka, Peter W, Liu, Yong-Yu, Spiegelman, Vladimir S, Whitfield, G Kerr, El Sayed, Khalid A
Published in International journal of molecular sciences (16.06.2018)

Get full text

Journal Article

The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104)

The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104)

by Xu, Song-Tao, Xi, Jun-Jie, Zhong, Wen-Zhao, Mao, Wei-Min, Wu, Lin, Shen, Yi, Liu, Yong-Yu, Chen, Chun, Cheng, Ying, Xu, Lin, Wang, Jun, Fei, Ke, Li, Xiao-Fei, Li, Jian, Huang, Cheng, Liu, Zhi-Dong, Xu, Shun, Chen, Ke-Neng, Xu, Shi-Dong, Liu, Lun-Xu, Yu, Ping, Wang, Bu-Hai, Ma, Hai-Tao, Yan, Hong-Hong, Yang, Xue-Ning, Zhang, Yong-Xing, Yin, Jia-Cheng, Wang, Qun, Wu, Yi-Long
Published in Journal of thoracic oncology (01.03.2019)

Get full text

Journal Article

N6‐methyladenosine‐RNA methylation promotes expression of solute carrier family 7 member 11, an uptake transporter of cystine for lipid reactive oxygen species scavenger glutathione synthesis, leading to hepatoblastoma ferroptosis resistance

N6‐methyladenosine‐RNA methylation promotes expression of solute carrier family 7 member 11, an uptake transporter of cystine for lipid reactive oxygen species scavenger glutathione synthesis, leading to hepatoblastoma ferroptosis resistance

by Hill, Ronald A., Liu, Yong‐Yu
Published in Clinical and translational medicine (01.05.2022)

Get full text

Journal Article

(-)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo

(-)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo

by Siddique, Abu Bakar, Ebrahim, Hassan Y, Akl, Mohamed R, Ayoub, Nehad M, Goda, Amira A, Mohyeldin, Mohamed M, Nagumalli, Suresh K, Hananeh, Wael M, Liu, Yong-Yu, Meyer, Sharon A, El Sayed, Khalid A
Published in Nutrients (15.02.2019)

Get full text

Journal Article

Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling

Glucosylceramide synthase upregulates MDR1 expression in the regulation of cancer drug resistance through cSrc and beta-catenin signaling

by Liu, Yong-Yu, Gupta, Vineet, Patwardhan, Gauri A, Bhinge, Kaustubh, Zhao, Yunfeng, Bao, Jianxiong, Mehendale, Harihara, Cabot, Myles C, Li, Yu-Teh, Jazwinski, S Michal
Published in Molecular cancer (11.06.2010)

Get full text

Journal Article

Incorporation of Fluorescence Ceramide-Based HPLC Assay for Rapidly and Efficiently Assessing Glucosylceramide Synthase In Vivo

Incorporation of Fluorescence Ceramide-Based HPLC Assay for Rapidly and Efficiently Assessing Glucosylceramide Synthase In Vivo

by Khiste, Sachin K., Hosain, Salman B., Dong, Yixuan, Uddin, Mohammad B., Roy, Kartik R., Hill, Ronald A., Liu, Zhijun, Liu, Yong-Yu
Published in Scientific reports (07.06.2017)

Get full text

Journal Article

Suppression of Glucosylceramide Synthase Restores p53-Dependent Apoptosis in Mutant p53 Cancer Cells

Suppression of Glucosylceramide Synthase Restores p53-Dependent Apoptosis in Mutant p53 Cancer Cells

by LIU, Yong-Yu, PATWARDHAN, Gauri A, BHINGE, Kaustubh, GUPTA, Vineet, XIN GU, MICHAL JAZWINSKI, S
Published in Cancer research (Chicago, Ill.) (15.03.2011)

Get full text

Journal Article

Novel Peptidomimetics for Inhibition of HER2:HER3 Heterodimerization in HER2-Positive Breast Cancer

Novel Peptidomimetics for Inhibition of HER2:HER3 Heterodimerization in HER2-Positive Breast Cancer

by Kanthala, Shanthi, Banappagari, Sashikanth, Gokhale, Ameya, Liu, Yong-Yu, Xin, Gu, Zhao, Yunfeng, Jois, Seetharama
Published in Chemical biology & drug design (01.06.2015)

Get full text

Journal Article

Low preoperative serum fibrinogen level is associated with postoperative acute kidney injury in patients with in acute aortic dissection

Low preoperative serum fibrinogen level is associated with postoperative acute kidney injury in patients with in acute aortic dissection

by Guan, Xin-Liang, Li, Lei, Jiang, Wen-Jian, Gong, Ming, Li, Hai-Yang, Liu, Yu-Yong, Wang, Xiao-Long, Zhang, Hong-Jia
Published in Journal of cardiothoracic surgery (07.01.2023)

Get full text

Journal Article

Assessment of Antitumor and Antiproliferative Efficacy and Detection of Protein-Protein Interactions in Cancer Cells from 3D Tumor Spheroids

Assessment of Antitumor and Antiproliferative Efficacy and Detection of Protein-Protein Interactions in Cancer Cells from 3D Tumor Spheroids

by Sonju, Jafrin Jobayer, Dahal, Achyut, Prasasty, Vivitri Dewi, Shrestha, Prajesh, Liu, Yong-Yu, Jois, Seetharama D
Published in Current protocols (01.10.2022)

Get more information

Journal Article

Gb3‐cSrc complex in glycosphingolipid‐enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via β‐catenin–activated RNA methylation

Gb3‐cSrc complex in glycosphingolipid‐enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via β‐catenin–activated RNA methylation

by Roy, Kartik R., Uddin, Mohammad B., Roy, Sagor C., Hill, Ronald A., Marshall, John, Li, Yu‐Teh, Chamcheu, Jean Christopher, Lu, Hua, Liu, Yong‐Yu
Published in FASEB bioAdvances (01.11.2020)

Get full text

Journal Article

1
2
3
4
5
6
7
8
9
10
11
Next
[14]